ArchPoint Investors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-41,021
| Closed | -$3.99M | – | 86 |
|
|
2021
Q1 | $3.99M | Hold |
41,021
| – | – | 1.13% | 19 |
|
|
2020
Q4 | $3.93M | Hold |
41,021
| – | – | 1.09% | 23 |
|
|
2020
Q3 | $3.95M | Buy |
41,021
+4,250
| +12% | +$409K | 1.26% | 15 |
|
|
2020
Q2 | $4.49M | Buy |
36,771
+500
| +1% | +$61K | 1.44% | 16 |
|
|
2020
Q1 | $3.14M | Sell |
36,271
-500
| -1% | -$43.3K | 1.24% | 18 |
|
|
2019
Q4 | $3.95M | Buy |
36,771
+500
| +1% | +$53.8K | 1.21% | 19 |
|
|
2019
Q3 | $3.27M | Sell |
36,271
-2,250
| -6% | -$203K | 1.11% | 20 |
|
|
2019
Q2 | $3.25M | Sell |
38,521
-625
| -2% | -$52.8K | 1.03% | 20 |
|
|
2019
Q1 | $3.45M | Buy |
39,146
+625
| +2% | +$55.1K | 1.03% | 19 |
|
|
2018
Q4 | $2.75M | Buy |
38,521
+22,553
| +141% | +$1.61M | 0.95% | 24 |
|
|
2018
Q3 | $1.96M | Hold |
15,968
| – | – | 0.53% | 32 |
|
|
2018
Q2 | $1.57M | Buy |
+15,968
| New | +$1.57M | 0.45% | 32 |
|